STOCK TITAN
  1. Home
  2. Sec-filings
  3. EXAS
  4. [144] Exact Sciences Corp SEC Filing

[144] Exact Sciences Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock EXAS logo
Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

#905 Ranked by Market Cap
N/A Ranked by Dividends

EXAS Latest News

Sep 10, 2025
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
Aug 19, 2025
Exact Sciences to Participate in September Investor Conferences
Aug 6, 2025
Exact Sciences Announces Second Quarter 2025 Results
Aug 6, 2025
Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests
Jul 31, 2025
Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test

EXAS Latest SEC Filings

Sep 8, 2025
[SCHEDULE 13G/A] Exact Sciences Corp SEC Filing
Aug 14, 2025
[Form 4] Exact Sciences Corp Insider Trading Activity
Aug 13, 2025
[144] Exact Sciences Corp SEC Filing
Aug 7, 2025
[Form 4] Exact Sciences Corp Insider Trading Activity
Aug 7, 2025
[Form 4] Exact Sciences Corp Insider Trading Activity

EXAS Stock Data

10.20B
186.97M
0.91%
95.58%
3.63%
Diagnostics & Research
Services-medical Laboratories
Link
United States
MADISON